Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
34.72
+0.05 (0.14%)
At close: Sep 11, 2026, 4:00 PM EDT
33.57
-1.15 (-3.31%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Avalyn Pharma Employees
Avalyn Pharma had 55 employees as of June 30, 2026. The number of employees increased by 5 or 10.00% since the number was reported on December 31, 2025.
Employees
55
Change
5
Growth
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,878,436
Market Cap
1.49B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 55 | 5 | 10.00% |
| Dec 31, 2025 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 828 |
| Novavax | 749 |
| Innoviva | 159 |
| Absci | 140 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
AVLN News
- 5 days ago - Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 5 days ago - Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis - GlobeNewsWire
- 19 days ago - Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026 - GlobeNewsWire
- 27 days ago - Avalyn Pharma price target raised to $57 from $53 at Morgan Stanley - TheFly
- 4 weeks ago - Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Avalyn Pharma Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Avalyn Pharma Earnings release: Q2 2026 - Filings
- 2 months ago - Avalyn Pharma completes target enrollment in MIST trial - TheFly